Tuesday, 25 June 2019

Pathogen engineered to self-destruct underlies cancer vaccine platform

A team of investigators has developed a cancer vaccine technology using live, attenuated pathogens as vectors. A feature of the vaccine causes these bacteria to self-destruct once they've done their job, making it safe for use in humans. The research is published in Infection and Immunity, a journal of the American Society for Microbiology.

* This article was originally published here